Literature DB >> 7582538

Cholinoceptor-mediated effects on glycerol output from human adipose tissue using in situ microdialysis.

K Andersson1, P Arner.   

Abstract

1. Possible cholinoceptor-mediated effects on lipolysis were investigated in vivo in human subcutaneous adipose tissue of non-obese, non-smoking, healthy subjects, by use of microdialysis. Cholinomimetic and sympathomimetic agents were added to the in going dialysate solvent. 2. Addition of nicotine to the perfusion solvent caused a concentration-dependent reversible increase in the levels of glycerol in the dialysate (lipolysis index). The opposite effect (also concentration-dependent and reversible) was caused by the addition of carbachol. The maximum effects were 100% stimulation and 50% inhibition, respectively, by nicotine and carbachol. Neither nicotine nor carbachol stimulated nutritive blood flow in adipose tissue (as measured with an ethanol escape technique). 3. The nicotine effect in situ was concentration-dependently counteracted by the nicotinic cholinoceptor antagonist, mecamylamine. Likewise, the carbachol effect was concentration-dependently counteracted by the muscarinic cholinoceptor antagonist, atropine. 4. When adipose tissue was pretreated with phentolamine plus propranolol in order to obtain a complete alpha and beta-adrenoceptor blockade, the subsequent addition of nicotine or carbachol still induced an increase and decrease in dialysate glycerol levels (lipolytic or antilipolytic effects), respectively. When adipose tissue was pretreated with mecamylamine or atropine, the subsequent addition of acetylcholine caused a reversible decrease and increase, respectively, of the dialysate glycerol levels. 5. Nicotine and carbachol had no effects on glycerol release from human isolated subcutaneous fat cells that were incubated in vivo. 6. In conclusion, the data demonstrate a dual effect of the cholinoceptor system on glycerol output inhuman adipose tissue: stimulation through nicotinic receptors and inhibition through muscarinic receptors. These effects, which are not observed in vitro, are independent of the adrenergic system and the local blood flow and seem not to be mediated by a direct action on the fat cell.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7582538      PMCID: PMC1908789          DOI: 10.1111/j.1476-5381.1995.tb15018.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  31 in total

Review 1.  The fat cell.

Authors:  J Hirsch; S K Fried; N K Edens; R L Leibel
Journal:  Med Clin North Am       Date:  1989-01       Impact factor: 5.456

Review 2.  Pharmacology of nicotine.

Authors:  J Grenhoff; T H Svensson
Journal:  Br J Addict       Date:  1989-05

Review 3.  Biochemical measurement of muscarinic receptor efficacy and its role in receptor regulation.

Authors:  S B Freedman; E A Harley; L L Iversen
Journal:  Trends Pharmacol Sci       Date:  1988-02       Impact factor: 14.819

4.  Adrenergic regulation of lipolysis in situ at rest and during exercise.

Authors:  P Arner; E Kriegholm; P Engfeldt; J Bolinder
Journal:  J Clin Invest       Date:  1990-03       Impact factor: 14.808

5.  Determination of brain interstitial concentrations by microdialysis.

Authors:  H Benveniste; A J Hansen; N S Ottosen
Journal:  J Neurochem       Date:  1989-06       Impact factor: 5.372

6.  Automatic luminometric kinetic assay of glycerol for lipolysis studies.

Authors:  J Hellmér; P Arner; A Lundin
Journal:  Anal Biochem       Date:  1989-02-15       Impact factor: 3.365

Review 7.  Blood circulation in adipose tissue.

Authors:  S Rosell; E Belfrage
Journal:  Physiol Rev       Date:  1979-10       Impact factor: 37.312

8.  Microdialysis in the study of extracellular levels of amino acids in the rat brain.

Authors:  U Tossman; U Ungerstedt
Journal:  Acta Physiol Scand       Date:  1986-09

9.  Differential effects of mecamylamine on the nicotine induced changes in amine levels and turnover in hypothalamic dopamine and noradrenaline nerve terminal systems and in the secretion of adenohypophyseal hormones in the castrated female rat. Evidence for involvement of cholinergic nicotine-like receptors.

Authors:  K Anderson; K Fuxe; P Eneroth; L F Agnati
Journal:  Acta Physiol Scand       Date:  1984-04

10.  Mecamylamine pretreatment counteracts cigarette smoke induced changes in hypothalamic catecholamine neuron systems and in anterior pituitary function.

Authors:  K Andersson
Journal:  Acta Physiol Scand       Date:  1985-11
View more
  6 in total

Review 1.  Circadian disruption and SCN control of energy metabolism.

Authors:  Andries Kalsbeek; Frank A Scheer; Stephanie Perreau-Lenz; Susanne E La Fleur; Chun-Xia Yi; Eric Fliers; Ruud M Buijs
Journal:  FEBS Lett       Date:  2011-03-21       Impact factor: 4.124

2.  Pten deletion in RIP-Cre neurons protects against type 2 diabetes by activating the anti-inflammatory reflex.

Authors:  Linyuan Wang; Darren Opland; Sue Tsai; Cynthia T Luk; Stephanie A Schroer; Margaret B Allison; Andrew J Elia; Caren Furlonger; Akira Suzuki; Christopher J Paige; Tak W Mak; Daniel A Winer; Martin G Myers; Minna Woo
Journal:  Nat Med       Date:  2014-04-20       Impact factor: 53.440

3.  A nitric oxide-mediated mechanism regulates lipolysis in human adipose tissue in vivo.

Authors:  K Andersson; N Gaudiot; C Ribiere; M Elizalde; Y Giudicelli; P Arner
Journal:  Br J Pharmacol       Date:  1999-04       Impact factor: 8.739

Review 4.  Mammalian nicotinic acetylcholine receptors: from structure to function.

Authors:  Edson X Albuquerque; Edna F R Pereira; Manickavasagom Alkondon; Scott W Rogers
Journal:  Physiol Rev       Date:  2009-01       Impact factor: 37.312

5.  Nicotine enhances ethanol-induced fat accumulation and collagen deposition but not inflammation in mouse liver.

Authors:  Yongke Lu; Stephen C Ward; Arthur I Cederbaum
Journal:  Alcohol       Date:  2013-05-31       Impact factor: 2.405

6.  Cigarette Smoking: An Accessory to the Development of Insulin Resistance.

Authors:  Ashley Artese; Bryant A Stamford; Robert J Moffatt
Journal:  Am J Lifestyle Med       Date:  2017-08-23
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.